Risperdal: Effective Atypical Antipsychotic for Symptom Control
| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $2.16 | $129.52 (0%) | 🛒 Add to cart |
| 90 | $1.80 | $194.28 $161.65 (17%) | 🛒 Add to cart |
| 180 | $1.44 | $388.57 $259.05 (33%) | 🛒 Add to cart |
| 270 | $1.32 | $582.85 $356.44 (39%) | 🛒 Add to cart |
| 360 | $1.26
Best per pill | $777.14 $453.83 (42%) | 🛒 Add to cart |
| Product dosage: 3mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.72 | $111.45 (0%) | 🛒 Add to cart |
| 60 | $2.93 | $222.90 $175.71 (21%) | 🛒 Add to cart |
| 90 | $2.68 | $334.35 $240.97 (28%) | 🛒 Add to cart |
| 120 | $2.55 | $445.80 $306.24 (31%) | 🛒 Add to cart |
| 180 | $2.42 | $668.70 $435.76 (35%) | 🛒 Add to cart |
| 270 | $2.33 | $1003.05 $629.54 (37%) | 🛒 Add to cart |
| 360 | $2.29
Best per pill | $1337.40 $825.33 (38%) | 🛒 Add to cart |
Risperdal (risperidone) is an atypical antipsychotic medication indicated for the treatment of schizophrenia, bipolar disorder, and irritability associated with autistic disorder. It functions by modulating dopamine and serotonin activity in the brain, offering a balanced approach to managing psychotic and mood-related symptoms. Clinically proven and widely prescribed, Risperdal provides reliable symptom control with a well-characterized safety profile, making it a cornerstone in psychiatric pharmacotherapy for both acute and maintenance phases of treatment.
Features
- Active ingredient: Risperidone
- Available formulations: Oral tablets, orally disintegrating tablets, and oral solution
- Mechanism: Dopamine D2 and serotonin 5-HT2A receptor antagonist
- FDA-approved for schizophrenia, bipolar mania, and irritability with autistic disorder
- Dosing flexibility with multiple strengths (0.25 mg to 4 mg tablets)
- Bioavailability not significantly affected by food
Benefits
- Reduces positive and negative symptoms of schizophrenia, such as hallucinations and social withdrawal
- Stabilizes mood episodes in bipolar I disorder, decreasing the frequency and severity of manic episodes
- Improves behavioral symptoms—including aggression, self-injury, and sudden mood changes—in autistic patients
- Lower risk of extrapyramidal symptoms compared to typical antipsychotics
- Once-daily dosing supports treatment adherence and long-term management
- Available in user-friendly formulations for individuals with swallowing difficulties
Common use
Risperdal is primarily prescribed for the management of schizophrenia in adults and adolescents aged 13 years and older. It is also used for the acute treatment of manic or mixed episodes associated with bipolar I disorder, as monotherapy or adjunctive therapy with lithium or valproate, in adults and pediatric patients aged 10 years and older. Additionally, it is indicated for the treatment of irritability—including aggression, deliberate self-injury, and temper outbursts—in children and adolescents aged 5 to 16 years with autistic disorder.
Dosage and direction
Dosage must be individualized based on clinical condition, patient response, and tolerability. For schizophrenia in adults, the initial dose is generally 2 mg per day, which may be increased to 4–6 mg per day by the third day. Maintenance doses typically range from 4–8 mg daily. For bipolar mania, start with 2–3 mg once daily; adjust in increments of 1 mg per day. In autistic disorder, begin with 0.25 mg per day for patients weighing <20 kg, and 0.5 mg per day for those ≥20 kg; titrate gradually. Administer once or twice daily, with or without food. Regular assessment is recommended to evaluate continued need and optimal dosing.
Precautions
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death; Risperdal is not approved for use in these patients. Monitor for signs and symptoms of neuroleptic malignant syndrome (NMS), a rare but potentially fatal reaction. Use with caution in patients with cardiovascular disease, seizures, or conditions that may predispose to hypotension. Risperdal may cause hyperprolactinemia; clinical consequences include galactorrhea, amenorrhea, and decreased bone density. Regularly monitor weight, as significant gain may occur. Avoid abrupt discontinuation; taper dose when discontinuing treatment.
Contraindications
Risperdal is contraindicated in patients with a known hypersensitivity to risperidone or any component of the formulation. Cross-sensitivity may occur among other antipsychotic agents. Do not use in patients with severe hepatic impairment, as clearance may be significantly reduced. Contraindicated in cases where there is a known risk of torsades de pointes or history of cardiac arrhythmias. Not for use in patients with dementia-related psychosis due to increased mortality risk.
Possible side effect
Common adverse reactions (≥5%) include: somnolence, dizziness, fatigue, constipation, dyspepsia, nausea, weight gain, increased appetite, dry mouth, salivary hypersecretion, blurred vision, upper respiratory tract infection, and tachycardia. Less frequently, extrapyramidal symptoms (such as tremor, rigidity, akathisia), orthostatic hypotension, hyperprolactinemia, and elevated creatine phosphokinase may occur. Rare but serious side effects include neuroleptic malignant syndrome, tardive dyskinesia, seizures, and diabetic ketoacidosis.
Drug interaction
Risperdal is primarily metabolized by CYP2D6. Concomitant use with strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) may increase risperidone plasma concentrations; dose adjustment may be necessary. Carbamazepine and other CYP3A4 inducers may decrease risperidone levels. Avoid combination with other centrally acting drugs due to additive sedative effects. Caution is advised when using with antihypertensive agents due to potential orthostatic hypotension. Risperdal may antagonize the effects of levodopa and dopamine agonists.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Consistent daily administration is important for maintaining therapeutic effect; consider setting reminders or using a pill organizer to support adherence.
Overdose
Symptoms of overdose may include drowsiness, sedation, tachycardia, hypotension, extrapyramidal symptoms, and QT prolongation. In severe cases, neuroleptic malignant syndrome or seizures may occur. There is no specific antidote for risperidone overdose. Provide supportive care, including continuous ECG monitoring, and maintain airway and vital functions. Gastric lavage and administration of activated charcoal may be considered if ingestion was recent. Contact a poison control center for latest guidance.
Storage
Store at controlled room temperature, 20°–25°C (68°–77°F), with excursions permitted between 15°–30°C (59°–86°F). Keep the container tightly closed and protect from light and moisture. Do not freeze the oral solution. Keep out of reach of children and pets. Dispose of unused medication properly via a drug take-back program or according to FDA guidelines.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or discontinuing any medication. Individual response to Risperdal may vary. Not all uses or risks are covered here; refer to the full prescribing information for complete details.
Reviews
Clinical studies and post-marketing surveillance support the efficacy and tolerability of Risperdal in indicated populations. Many clinicians report satisfactory symptom control and functional improvement in patients with schizophrenia and bipolar disorder. In pediatric autistic populations, caregivers often note reduced irritability and improved behavior. Long-term use requires ongoing monitoring for metabolic and neurological side effects. Overall, Risperdal remains a well-regarded option within its class.